Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

As yet, no direct-acting antiviral drugs have demonstrated efficacy in the disease. In contrast, increasing evidence indicates an immune-mediated pathophysiology that is paving the way for the evaluation of immunomodulation strategies [2]. In support of this view, we would like to highlight the striking similarities between COVID-19 and a rare autoimmune disease: the anti-MDA5-syndrome.

Source: European Respiratory Journal - September 23, 2020 Category: Respiratory Medicine Authors: Giannini, M., Ohana, M., Nespola, B., Zanframundo, G., Geny, B., Meyer, A. Tags: Original Articles: Correspondence Source Type: research